The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Is Resolution the End of Inflammation?
Open accessAbstract
Deciphering the origins of chronic inflammatory and autoimmune diseases remains elusive with reliance on therapies aimed at halting inflammation in its tracks. In recent years, an appreciation of targeting pathways by which inflammation is resolved has begun to rouse interest. Resolution of inflammation is driven by a complex set of mediators that regulate cellular events required to clear inflammatory cells from sites of infection or injury to restore tissue function. However, recent studies suggest that resolution is not the end of innate mediated immune responses to infection/injury. There is further immunological activity occurring after the resolution cascade is complete that alters the immune physiology of tissues, redefining what was once termed restorative homeostasis as adapted homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We now appreciate that switching off inflammation is an equally involved process with distinct signalling and effector pathways all of which impact downstream immune responses (32).”
From The impact of ageing on monocytes and macrophages (2021) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,634
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245
Flagged first, then by citations
Research works printed but not linked: 1
- Ariel, 2006, Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression, Nat. Immunol., 7, 1209, 10.1038/ni1392 · DOI
Cited by
Sorted by citations
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 3,058
Modulation of the Inflammatory Response and Bone Healing
Maruyama, M., Rhee, C., Utsunomiya, T., Zhang, N., Ueno, M., Yao, Z., & Goodman, S. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00386 · Cited by 541
“However, more recently, the resolution of inflammation is thought to be an active process, regulated by various mediators and immune cells (13).”
BackgroundFlavonoids and their role in oxidative stress, inflammation, and human diseases
Jomová, K., Alomar, S. Y., Valko, R., Líška, J., Nepovimová, E., Kuča, K., & Valko, M. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111489 · Cited by 449
Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis
Wang, K., Yin, J., Chen, J., Ma, J., Si, H., & Xia, D. (2024) · Phytomedicine · doi:10.1016/j.phymed.2023.155258 · Cited by 301
The impact of ageing on monocytes and macrophages
De Maeyer, R. P. H., & Chambers, E. S. (2021) · Immunology Letters · doi:10.1016/j.imlet.2020.12.003 · Cited by 275
“6 | P a g e pathways all of which impact downstream immune responses (32).”
BackgroundEmerging Role of cAMP/AMPK Signaling
Aslam, M., & Ladilov, Y. (2022) · Cells · doi:10.3390/cells11020308 · Cited by 241
“Inflammation is an adaptive response triggered by noxious stimuli and conditions such as infection and tissue injury [89].”
BackgroundPillon, N. J., Loos, R. J. F., Marshall, S. M., & Zierath, J. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.012 · Cited by 247
“The immune response comes in waves, starting with a pro-inflammatory activation and finishing with a resolving anti-inflammatory phase (Feehan and Gilroy, 2019).”
Ge, J., Liu, Z., Zhong, Z., Wang, L., Zhuo, X., Li, J., Jiang, X., Ye, X., Xie, T., & Bai, R. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105817 · Cited by 183
Richard, S. A. (2021) · Mediators of Inflammation · doi:10.1155/2021/6699560 · Cited by 184
“The fundamental processes involved in the eradication of threats posed to the host to organisms like bacterial and viral infections are the triggering of an acute inflammatory response [35].”
Inflammatory Networks Linking Oral Microbiome with Systemic Health and Disease
Kleinstein, S. E., Nelson, K. E., & Freire, M. (2020) · Journal of Dental Research · doi:10.1177/0022034520926126 · Cited by 176
Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Yu, W., Tu, Y., Long, Z., Liu, J., Kong, D., Peng, J., Wu, H., Zheng, G., Zhao, J., Chen, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2606928 · Cited by 168
“If the irritations persist, aggregation of inflammatory cells and cytokines can transform acute inflammation into the chronic stage, potentially inducing local and systemic deleterious effects [62].”
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 154
Laurindo, L. F., de Carvalho, G. M., Zanuso, B. D. O., Figueira, M. E., Direito, R., Goulart, R. D. Á., Buglio, D. S., & Barbalho, S. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010229 · Cited by 133
Biological processes and factors involved in soft and hard tissue healing
Bartold, P. M., & Ivanovski, S. (2024) · Periodontology 2000 · doi:10.1111/prd.12546 · Cited by 111
Role of Histone Post-Translational Modifications in Inflammatory Diseases
Lin, Y., Qiu, T., Wei, G., Que, Y., Wang, W., Kong, Y., Xie, T., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852272 · Cited by 96
“It is a frequent occurrence to protect organisms from the spread of infection and recover the affected compartments to a normal state, which is called “resolution” (2).”
BackgroundYao, Z., Qi, W., Zhang, H., Zhang, Z., Liu, L., Shao, Y., Zeng, H., Yin, J., Pan, H., Guo, X., et al. (2023) · eLife · doi:10.7554/elife.83069 · Cited by 88
“The balance of progression and regression that controls the state of local inflammation has recently been in the spotlight ( Oishi and Manabe, 2018 ; Feehan and Gilroy, 2019 ).”
Negreiros-Lima, G. L., Lima, K. M., Moreira, I. Z., Jardim, B. L. O., Vago, J. P., Galvão, I., Teixeira, L. C. R., Pinho, V., Teixeira, M. M., Sugimoto, M. A., et al. (2020) · Cells · doi:10.3390/cells9010128 · Cited by 80
“If successful, the inflammatory response tends to progress from the onset to the post-resolution phase through a coordinated series of molecular and cellular events that lead to the restoration of tissue structure, organ function, and ‘adapted homeostasis’ [5].”
BackgroundWei, Y., Meng, Y., Li, N., Wang, Q., & Chen, L. (2020) · Food & Function · doi:10.1039/d0fo01976c · Cited by 84
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Zhang, S., Meng, Y., Zhou, L., Qiu, L., Wang, H., Su, D., Zhang, B., Chan, K. M., & Han, J. (2022) · MedComm · doi:10.1002/mco2.173 · Cited by 85
Liu, F., Wu, J., Gong, L.-J., Yang, H.-S., & Chen, H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1490300 · Cited by 90
Desmosomes as Signaling Hubs in the Regulation of Cell Behavior
Müller, L., Hatzfeld, M., & Keil, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.745670 · Cited by 81
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease
Fu, T., Mohan, M., Brennan, E. P., Woodman, O. L., Godson, C., Kantharidis, P., Ritchie, R. H., & Qin, C. X. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00097 · Cited by 81
Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action
Anil, S. M., Peeri, H., & Koltai, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.908198 · Cited by 76
Myeloid-derived suppressor cells (MDSC): When good intentions go awry
Sanchez‐Pino, M. D., Dean, M. J., & Ochoa, A. C. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104302 · Cited by 72
Potential use of antioxidants for the treatment of chronic inflammatory diseases
Blagov, A. V., Summerhill, V. I., Sukhorukov, V. N., Zhigmitova, E. B., Postnov, A. Y., & Orekhov, A. N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1378335 · Cited by 80
Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics
Liu, Y., Lin, Z., Wang, Y., Chen, L., Wang, Y., & Luo, C. (2024) · Theranostics · doi:10.7150/thno.91394 · Cited by 72
“However, long-term inflammatory reactions can lead to the dysfunction of cells, tissues, organs and living systems, and also increase the risks of chronic diseases [2].”
BackgroundThe Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
Rakotoarivelo, V., Mayer, T. Z., Simard, M., Flamand, N., & Marzo, V. D. (2024) · Molecules · doi:10.3390/molecules29143381 · Cited by 72
“These disorders evolve from a sustained activation of the immune system that can be localized and/or disseminated throughout the body [3].”
BackgroundTargeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases
Cannon, A. S., Nagarkatti, P. S., & Nagarkatti, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010288 · Cited by 72
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Do, K. V., Hjorth, E., Wang, Y., Jun, B., Kautzmann, M.-A. I., Ohshima, M., Eriksdotter, M., Schultzberg, M., & Bazan, N. G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01216-5 · Cited by 67
“However, in addition to the role of PGs at the initiation of an inflammatory response (Serhan and Savill 2005), it is hypothesized that there is a post-resolution immunological activity during which PGE2 may exert modulatory and anti-inflammatory effects (Feehan and Gilroy 2019).”
BackgroundAnti-inflammatory potential of ulvan
Flórez-Fernández, N., Rodríguez-Coello, A., Latire, T., Bourgougnon, N., Torres, M. D., Buján, M., Muíños, A., Muiños, A., Meijide-Faílde, R., Blanco, F. J., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126936 · Cited by 67
Carvalheiro, T., García, S., Ramos, M., Giovannone, B., Radstake, T., Marut, W., & Meyaard, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01793 · Cited by 60
“Uncontrolled inflammation is a key player in the pathogenesis of many chronic conditions and a persistent inflammatory response can lead to significant tissue and organ damage (3, 4).”
BackgroundAlterations of Lipid Profile in COVID-19: A Narrative Review
Rezaei, A., Neshat, S., & Heshmat‐Ghahdarijani, K. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100907 · Cited by 63
Yi, J., Li, L., Yin, Z.-J., Quan, Y., Tan, R., Chen, S., Lang, J., Li, J., Zeng, J., Li, Y., et al. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3598-z · Cited by 59
Gao, J., Dong, X., Su, Y., & Wang, Z. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.01.020 · Cited by 60
“Inflammatory diseases are associated with the failure of inflammation resolution after infections [34, 35].”
BackgroundLipoxin Mimetics and the Resolution of Inflammation
Godson, C., Guiry, P. J., & Brennan, E. P. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-085407 · Cited by 59
Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
Torrinhas, R. S., Calder, P. C., Lemos, G., & Waitzberg, D. L. (2020) · Nutrition · doi:10.1016/j.nut.2020.110900 · Cited by 58
“Although they decrease proinflammatory mediator synthesis and neutrophil recruitment, they activate macrophages with an antiinflammatory phenotype (M2) and stimulate phagocytosis in a non-phlogistic manner [32].”
BackgroundImmune Response to Borrelia : Lessons from Lyme Disease Spirochetes
Bockenstedt, L. K., Wooten, R. M., & Baumgarth, N. (2020) · Current Issues in Molecular Biology · doi:10.21775/cimb.042.145 · Cited by 66
Livshits, G., & Kalinkovich, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101852 · Cited by 56
Inflammation, Mitochondria and Natural Compounds Together in the Circle of Trust
Nesci, S., Spagnoletta, A., & Oppedisano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076106 · Cited by 57
“Dysregulation of these processes can lead to uncontrolled chronic inflammation, resulting in the development of several associated diseases such as cardiovascular disease, atherosclerosis, Type 2 diabetes, rheumatoid arthritis, and cancers [37,38].”
BackgroundWylezinski, L. S., Gray, J. D., Polk, J. B., Harmata, A. J., & Spurlock, C. F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040493 · Cited by 50
“However, when the immune system becomes dysregulated, it can cause serious harm and even lead to tissue and organ system destruction in the case of prolonged inflammation [1].”
BackgroundSong, Y., Hu, J., Ma, C., Liu, H., Li, Z., & Yang, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s449388 · Cited by 46
“(5 ) Most previous studies about inflammation have focused on the therapeutic effects of M-Exos on miRNAs, but proteins, lncRNAs, circRNAs and some other bioactive molecules may also participate in the function of exosomes.”
BackgroundFélix, F. B., Vago, J. P., Fernandes, D. D. O., Martins, D. G., Zaidan, I., Gonçalves, W. A., Costa, W. C., Araújo, J. M. D., Queiroz‐Junior, C. M., Campolina-Silva, G. H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.662308 · Cited by 44
“The resolution of inflammation is a complex process and actively orchestrated by specialized pro-resolving mediators that collaborate efficiently to inhibit the influx of leukocytes to the inflamed site, shutting down molecules of intracellular pathways associated with cytokine production and leukocyte survival (espec…”
BackgroundCarvalho, J. D. S., Ramadan, D., Gonçalves, V. D. P., Maquera-Huacho, P. M., Assis, R. P., Lima, T. F. O., Brunetti, I. L., Spolidório, D. M. P., Cesar, T. B., Manthey, J. A., et al. (2021) · Food & Function · doi:10.1039/d0fo03338c · Cited by 43
Macrophage Activation in the Synovium of Healthy and Osteoarthritic Equine Joints
Menarim, B. C., Gillis, K. H., Oliver, A., Ngo, Y., Werre, S. R., Barrett, S. H., Rodgerson, D. H., & Dahlgren, L. A. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.568756 · Cited by 45
Effects of Anthraquinones on Immune Responses and Inflammatory Diseases
Xin, D., Li, H., Zhou, S., Zhong, H., & Pu, W. (2022) · Molecules · doi:10.3390/molecules27123831 · Cited by 43
“Inflammation is a defense response of the body to stimuli, manifested as redness, swelling, heat, pain and dysfunction [7].”
BackgroundGonzalez, A. L., Dungan, M. M., Smart, C. D., Madhur, M. S., & Doran, A. C. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0284 · Cited by 42
“Cytokines and chemokines already present within the tissue undergo cleavage and sequestration, preventing them from binding and activating their cognate receptors (Charo and Ransohoff, 2006; Feehan and Gilroy, 2019).”
Moreira, V., Leiguez, E., Janovits, P. M., Maia-Marques, R., Fernándes, C. M., & Teixeira, C. (2021) · Toxins · doi:10.3390/toxins13120868 · Cited by 43
How do sphingosine-1-phosphate affect immune cells to resolve inflammation?
Sun, G., Wang, B., Wu, X., Cheng, J., Ye, J., Wang, C., Zhu, H., & Liu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1362459 · Cited by 38
Local Immunomodulatory Effects of Intracanal Medications in Apical Periodontitis
Hussein, H., & Kishen, A. (2022) · Journal of Endodontics · doi:10.1016/j.joen.2022.01.003 · Cited by 44
Gugliandolo, E., Peritore, A. F., Piras, C., Cuzzocrea, S., & Crupi, R. (2020) · Veterinary Sciences · doi:10.3390/vetsci7020078 · Cited by 37
“It is generally believed that a controlled inflammatory response is beneficial, but it can become detrimental if dysregulated, with uncontrolled inflammation being a key player in the pathogenesis of several diseases [110,111].”
BackgroundWang, R., Shi, X. L., Li, K., Bunker, A., & Li, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125120 · Cited by 38
Anti-Inflammatory Activity of a Peptide from Skipjack (Katsuwonus pelamis)
Wang, Z., Ying, X., Gao, P., Wang, C., Wang, Y., Yu, X.-W., Chen, J., Wang, B., & Luo, H. (2019) · Marine Drugs · doi:10.3390/md17100582 · Cited by 35
“The most widely used inflammation treatment approach is to inhibit the synthesis or action of mediators that drive inflammation using drugs including nonsteroidal anti-inflammatory drugs (NSAIDs) and anticytokine therapies, such as anti-tumor necrosis factor (TNF)-α [4].”
BackgroundTomiyama, T., Itoh, S., Iseda, N., Toshida, K., Morinaga, A., Yugawa, K., Kosai‐Fujimoto, Y., Tomino, T., Kurihara, T., Nagao, Y., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13213 · Cited by 33
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review
Romano, M., Patruno, S., Pomilio, A., & Recchiuti, A. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0078 · Cited by 34
Sousa, L. P., Pinho, V., & Teixeira, M. M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15164 · Cited by 32
“However, tissues tend not to return completely to their pre-inflamed state, in terms of cellular composition and phenotype, as previously thought, but to a state of “adapted homoeostasis,” which modifies the severity of subsequent inflammatory responses (Feehan & Gilroy, 2019).”
BackgroundNon-inflammatory Physiology of “Inflammatory” Mediators – Unalamation, a New Paradigm
Maddipati, K. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580117 · Cited by 32
“While antiinflammatory properties also were attributed to COX-2, its role is in the resolution of inflammation rather than its inhibition (6, 15, 66).”
BackgroundLin, Y., Liu, S., Sun, Y., Chen, C., Yang, S., Pei, G., Lin, M., Yu, J., Liu, X., Wang, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102286 · Cited by 33
Transcriptomics of type 2 diabetic and healthy human neutrophils
Kleinstein, S. E., McCorrison, J., Ahmed, A. R., Hastürk, H., Dyke, T. E. V., & Freire, M. (2021) · BMC Immunology · doi:10.1186/s12865-021-00428-6 · Cited by 31
Friuli, M., Eramo, B., Valenza, M., Scuderi, C., Provensi, G., & Romano, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910250 · Cited by 33
Qin, F., Zhang, H., Di, Q., Wang, Y., Yan, Y., Chen, W., & Cheng, Y. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c00452 · Cited by 30
Tissue compartmentalization enables Salmonella persistence during chemotherapy
Li, J., Claudi, B., Fanous, J., Chicherova, N., Cianfanelli, F. R., Campbell, R. A. A., & Bumann, D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113951118 · Cited by 29
Inflammation resolution in environmental pulmonary health and morbidity
Marzec, J. M., & Nadadur, S. S. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116070 · Cited by 29
Ferreira, B. L., Ferreira, D. P., Borges, S. F., Ferreira, A. M., Holanda, F. H., Ucella-Filho, J. G. M., Cruz, R. A. S., Birolli, W. G., Luque, R., & Ferreira, I. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1207664 · Cited by 28
“This process aims to block, inactivate, or eliminate harmful agents (Borges et al., 2018; Feehan and Gilroy, 2019).”
BackgroundAmador‐Martínez, I., Aparicio‐Trejo, O. E., Bernabe-Yepes, B., Aranda‐Rivera, A. K., Cruz‐Gregorio, A., Sánchez‐Lozada, L. G., Pedraza‐Chaverrí, J., & Tapia, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115875 · Cited by 28
Manginstar, C., Tallei, T. E., Niode, N. J., Salaki, C. L., & Hessel, S. S. (2023) · Phytotherapy Research · doi:10.1002/ptr.8092 · Cited by 32
“Inflammation resolution is the process of restoring tissue homeostasis and preventing the development of chronic inflammation (Feehan & Gilroy, 2019).”
BackgroundLi, H., Ruan, J., Huang, J., Yang, D., Yu, H., Wu, Y. C., Zhang, Y., & Wang, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417538 · Cited by 28
Role of Tristetraprolin in the Resolution of Inflammation
Rappl, P., Brüne, B., & Schmid, T. (2021) · Biology · doi:10.3390/biology10010066 · Cited by 26
“In fact, successful resolution is not the end of this dynamic process, but recent reports indicate that it is followed by a prolonged post-resolution phase characterized by an altered, immune suppressive environment [28,29].”
BackgroundLiu, Z., Yu, W., Zhou, H., Lan, Z., Wu, T., Xiong, S., Yan, L., & Liu, H. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13889 · Cited by 27
Menarim, B. C., Gillis, K. H., Oliver, A., Mason, C., Werre, S. R., Luo, X., Byron, C. R., Kalbfleisch, T., MacLeod, J. N., & Dahlgren, L. A. (2020) · The FASEB Journal · doi:10.1096/fj.201902698r · Cited by 26
Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis
Batarfi, W. A., Yunus, M. H. M., Hamid, A. A., Lee, Y. T., & Maarof, M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121504 · Cited by 25
Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases
Andrews, D. C., & Godson, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158940 · Cited by 27
Complement activation links inflammation to dental tissue regeneration
Bergmann, M., Jeanneau, C., Giraud, T., Richard, G., & About, I. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03621-w · Cited by 24
“This is followed by the inflammation resolution which is regulated by multiple mediators and immune cells [3].”
BackgroundBlood-based biomarkers of chronic inflammation
Pritzker, K. P. H. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2215928 · Cited by 24
Promising Antioxidant Activity of Erythrina Genus: An Alternative Treatment for Inflammatory Pain?
Cabrera, T. J., Bautista, M., Velázquez, C., Jaramillo‐Morales, O. A., Guerrero-Solano, J. A., Urrutia-Hernández, T. A., & la O‐Arciniega, M. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010248 · Cited by 27
“Several mediators are involved in the inflammatory pathway, prostaglandins, leukotrienes, cytokines, plateletactivating factor, and chemokines [89].”
BackgroundThe role of miR-155 on liver diseases by modulating immunity, inflammation and tumorigenesis
Xue, X., Wang, J., Fu, K., Dai, S., Wu, R. T., Peng, C., & Li, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109775 · Cited by 24
Effects of fermented dairy products on inflammatory biomarkers: A meta-analysis
Zhang, X., Luo, Q., Guan, X.-X., Tang, Y., Chen, X., Deng, J., & Fan, J. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.12.014 · Cited by 25
Epithelial Barrier: Protector and Trigger of Allergic Disorders
Izquierdo, E., Rodríguez‐Coira, J., Dolset, M. I. D., Gómez‐Casado, C., Barber, D., & Escribese, M. M. (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0779 · Cited by 24
“…tissue does not return to previous homeostasis, but rather achieves an adapted homeostatic state in which, despite recovery of organ architecture and function, there are changes in cellular composition and phenotype, thus affecting the severity of future inflammatory responses [143,158,159].”
BackgroundLuo, J., Zhang, W.-Y., Li, H., Zhang, P.-H., Tian, C., Wu, C.-H., Zhao, A.-N., Chen, M.-L., Guo, Y.-F., Cho, Y.-C., et al. (2021) · Shock · doi:10.1097/shk.0000000000001865 · Cited by 21
“Previous studies report that ChemR23 and BLT1 are specific receptors for RvE1 (20).”
BackgroundInflammation and Exosomes in Fabry Disease Pathogenesis
Coelho-Ribeiro, B., Silva, H., Sampaio‐Marques, B., Fraga, A. G., Azevedo, O. M., Pedrosa, J., & Ludovico, P. (2024) · Cells · doi:10.3390/cells13080654 · Cited by 20
Radbakhsh, S., Katsiki, N., Santos, R. D., Mikhailidis, D. P., Mantzoros, C. S., & Sahebkar, A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155211 · Cited by 20
A multifunctional nanoparticle for efferocytosis and pro-resolving-mediated endometriosis therapy
Sun, Q., Lei, Y., Zhang, H., Ding, X., Yang, M., Zhang, T., Chen, J., Huang, Z., Wang, L., Lan, J., et al. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112893 · Cited by 22
Resolution pharmacology and the treatment of infectious diseases
Costa, V. V., Resende, F., Melo, E. M., & Teixeira, M. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16323 · Cited by 19
“A review of the data that has led to their classification as pro-resolving molecules is beyond the scope of the current review but can be found in other recent reviews on the subject (see Feehan & Gilroy, 2019; Panigrahy et al., 2021; Sugimoto et al., 2019).”
BackgroundWu, J., Xie, J., Chen, Y., Fu, X., Wang, R., Deng, Y.-Y., Wang, S., Yu, H., Liang, C., & Yu, Z. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154194 · Cited by 20
The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
Sousa, A. B., & Barbosa, J. N. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14040223 · Cited by 21
“(Cys-SPMs) and n-3 docosapentaenoic acid (DPA)-derived SPMs (n-3 DPA-derived SPMs) [18].”
BackgroundInfluentialHou, C., Zhang, X., Wei, J., Wang, J.-N., Gao, J., Wang, Z.-J., Xie, S.-S., Chen, T., Sun, T., Pu, T., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adv4810 · Cited by 22
NLRP3 Inflammasome: a Novel Insight into Heart Failure
Wang, Y., Li, Y., Zhang, W., Yuan, Z., Lv, S., & Zhang, J. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10286-1 · Cited by 19
“Inflammation is the organism’s first immune defense against harmful stimuli, which occurs when the organism receives exogenous infection and endogenous cell tissue damage [11, 12].”
BackgroundHawkshaw, N. J., Pilkington, S. M., Murphy, S. A., Al‐Gazaq, N., Farrar, M. D., Watson, R. E. B., Nicolaou, A., & Rhodes, L. E. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1104 · Cited by 18
“initiating inflammatory signal has subsided, a beneficial state of local immunosuppression remains.(8) This post-resolution phase is characterised by either a secondary infiltrate(9,10) or retention of immune cells following inflammatory resolution, and maintains an immunosuppressive environment.”
BackgroundWang, J.-Y., Xing, Y.-X., Li, M.-Y., Zhang, Z.-H., Jin, H.-L., Ma, J., Lee, J., Zhong, Y., Zuo, H.-X., & Jin, X.-J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114715 · Cited by 16
Signaling Pathways in Inflammation and Its Resolution: New Insights and Therapeutic Challenges
Cicala, C., & Morello, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311055 · Cited by 16
“In recent years, the research in this field has been working towards clarifying these pro-resolving pathways and signaling pathways that may be targets for therapeutic intervention [1,2].”
BackgroundSalminen, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102926 · Cited by 15
Menarim, B. C., MacLeod, J. N., & Dahlgren, L. A. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i7.825 · Cited by 16
Han, L., Wu, X., Wang, O., Luan, X., Velander, W. H., Aynardi, M. C., Halstead, E. S., Bonavia, A. S., Jin, R., Li, G., et al. (2023) · Theranostics · doi:10.7150/thno.83942 · Cited by 14
“These mechanisms, designed to work together to prevent severe inflammation, often fail in patients with severe medical comorbidities and/or compromised immunity [3,4].”
Xu, J., Zhou, L., Sun, L., Wang, Z., Wang, Y., Wang, Y., & He, X. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00990 · Cited by 15
Diversity-oriented synthesis of diterpenoid alkaloids yields a potent anti-inflammatory agent
Li, X., Zhang, J., Chen, Q., Tang, P., Zhang, T., Feng, Q., Chen, J., Liu, Y., Peng, C. Y., Peng, C. Y., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154907 · Cited by 14
Tonic Meningeal Interleukin-10 Upregulates Delta Opioid Receptor to Prevent Relapse to Pain
Inyang, K. E., Sim, J., Clark, K. B., Geron, M., Monahan, K., Evans, C., O’Connell, P., Laumet, S., Peng, B., Ma, J., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.09.031 · Cited by 14
Flaxseed Ethanol Extract Effect in Acute Experimental Inflammation
Chera, E. I., Pop, T. I., Pop, R. M., Pârvu, M., Uifălean, A., Cătoi, A. F., Cecan, A. D., Mîrza, C.-M., Achimaș-Cădariu, P., & Pârvu, A. E. (2022) · Medicina · doi:10.3390/medicina58050582 · Cited by 15
“Moreover, it was suggested that this can be a risk for the development of chronic inflammation [1], because, in many chronic conditions, the”
Backgroundde Oliveira, V. L. S., Pollenus, E., Berghmans, N., Queiroz‐Junior, C. M., Blanter, M., Mattos, M. S., Teixeira, M. M., Proost, P., den Steen, P. E. V., Amaral, F. A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112920 · Cited by 14
“The resolution of lung inflammation requires an orchestrated immune response and several control mechanisms to avoid excessive inflammation and chronic disease [28,29].”
BackgroundControlling Inflammation Improves Aging Skeletal Muscle Health
Fountain, W. A., Naruse, M., Claiborne, A., Trappe, S. W., & Trappe, T. A. (2023) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000313 · Cited by 15
Zhuo, X., Wu, Y., Fu, X., Li, J., Xiang, Y., Liang, X., Mao, C., & Jiang, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.013 · Cited by 12
Magalhães, G. S., Gregório, J. F., Beltrami, V. A., Félix, F. B., Oliveira-Campos, L., Bonilha, C. S., Righetti, R. F., Tibério, I. D. F. L. C., Sousa, F. B. D., Rezende, B. M., et al. (2024) · Inflammation Research · doi:10.1007/s00011-024-01880-x · Cited by 12
Metadata
- Authors
- Feehan, K. T., & Gilroy, D. W.
- Affiliations
- University College London (GB)
- Corresponding author
- Gilroy, Derek W.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 25
- Issue
- 3
- Pages
- 198-214
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2918019780
- Cited by
- 229
- References
- 148
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 40 · 2023: 43 · 2022: 37 · 2021: 30 · 2020: 22 · 2019: 3
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Biotechnology and Biological Sciences Research Council (1788941)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- inflammation resolution, chronic inflammation, autoimmune disease, innate immunity, adaptive homeostasis, tissue repair, inflammatory mediators
- MeSH terms
- Acute Disease, Animals, Chronic Disease, Disease Susceptibility, Humans, Immunity, Inflammation, Signal Transduction, Biomarkers, Cytokines, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review